Arab | NHWa | NHBb | Hispanic | Asian | AI_Alc | p-value | ||
---|---|---|---|---|---|---|---|---|
(n=94) | (n=6,035) | (n=1,085) | (n=1,415) | (n=449) | (n=19) | |||
n (%) | n(%) | n(%) | n(%) | n(%) | n(%) | |||
Estrogen Receptor d | ||||||||
Positive | 38 (42.2%) | 2,219 (39.3%) | 332 (32.1%) | 491 (36.4%) | 156 (36.7%) | 7 (36.8%) | 0.0070 | |
Negative | 36 (40.0%) | 1,833 (32.4%) | 391 (37.7%) | 474 (35.1%) | 156 (36.7%) | 7 (36.8%) | ||
Unknown | 16 (17.8%) | 1,598 (28.3) | 313 (30.2%) | 384 (28.5%) | 113 (26.6%) | 5 (26.3%) | ||
Progesterone Receptor d | ||||||||
Positive | 23 (25.6%) | 1,762 (31.2%) | 252 (24.3%) | 380 (28.2%) | 117 (27.5%) | 4 (21.1%) | 0.0003 | |
Negative | 50 (55.5%) | 2,195 (38.8%) | 453 (43.7%) | 570 (42.2%) | 189 (44.5%) | 10 (52.6%) | ||
Unknown | 17 (18.9%) | 1,693 (30%) | 331 (32%) | 399 (29.6%) | 119 (28%) | 5 (26.3%) | ||
Combined Hormonal Status e | ||||||||
ER+ PR+ | 20 (27.4%) | 1,597 (40.6%) | 222 (31.6%) | 336 (35.7%) | 108 (35.3%) | 4 (28.6%) | 0.0002 | |
ER+ PR- | 17 (23.3%) | 538 (13.7%) | 98 (14%) | 136 (14.4%) | 44 (14.4%) | 3 (21.4%) | 0.0948 | |
ER- PR+ | 3 (4.1%) | 158 (4.0%) | 28 (4%) | 42 (4.5%) | 9 (2.9%) | 0 (0%) | 0.8900 | |
ER- PR - | 33 (45.2%) | 1,642 (41.7%) | 354 (50.4%) | 428 (45.4%) | 145 (47.4%) | 7 (50.0%) | 0.0129 | |
Her-2 Receptor f | ||||||||
Positive | 14 (29.2%) | 594 (21.9%) | 94 (17.9%) | 248 (29.9%) | 83 (31.1%) | 2(18.2%) | <0.0001 | |
Negative | 12 (25.0%) | 906 (33.4%) | 166 (31.7%) | 310 (37.3%) | 91 (34.1%) | 5 (45.5%) | ||
Unknown | 22 (45.8%) | 1,209 (44.6%) | 264 (50.4%) | 272 (32.8%) | 93 (34.8%) | 4 (36.3%) | ||
Education g | ||||||||
High | 36 (38.3%) | 2,233 (37.0%) | 183 (16.9%) | 198 (14.0%) | 128 (28.5%) | 3 (15.8%) | <0.0001 | |
Middle | 30 (31.9%) | 2,021 (33.5%) | 249 (23.0%) | 262 (18.5%) | 127 (28.3%) | 8 (42.1%) | ||
Low | 28 (29.8%) | 1,781 (29.5%) | 653 (60.2%) | 955 (67.5%) | 194 (43.2%) | 8 (42.1%) | ||
Menopausal Status | ||||||||
Pre (<50 yr) | 25 (26.6%) | 1,565 (25.9%) | 389 (35.9%) | 648 (45.8%) | 162 (36.1%) | 8 (42.1%) | <0.0001 | |
Post (≥50 yr) | 69 (73.4%) | 4,470 (74.1%) | 696 (64.1%) | 767 (54.2%) | 287 (63.9%) | 11 (57.9%) | ||
%No Education g | 18.6 (15) | 17.7 (13) | 29.4 (18) | 35.2 (21) | 23.7 (17) | 28.8 (18) | <0.0001 | |
Age at diagnosis | 58.5 (11.7) | 60.1 (14.6) | 56.2 (14.5) | 52.6 (14) | 54.0 (12.5) | 54.8 (12.7) | <0.0001 | |
Survival (months) | 50.5 (51.3) | 47.6 (49.3) | 33.2 (37.5) | 43.1 (44.2) | 49.7 (47.4) | 24.8 (25.7) | <0.0001 |